RedHill Biopharma reported $2.69M in EBITDA for its fiscal quarter ending in June of 2023.





Ebitda Change Date
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -7.89M 536K Sep/2025
Cronos Group USD 5.68M 3.99M Sep/2025
RedHill Biopharma USD 2.69M 108.46M Jun/2023